Unique ID issued by UMIN | UMIN000037217 |
---|---|
Receipt number | R000042173 |
Scientific Title | Systematic review and meta-analysis of acceptance&commitment therapy for type 2 diabetes |
Date of disclosure of the study information | 2019/07/01 |
Last modified on | 2019/06/11 06:31:16 |
Systematic review and meta-analysis of acceptance&commitment therapy for type 2 diabetes
Systematic review and meta-analysis of acceptance&commitment therapy for type 2 diabetes
Systematic review and meta-analysis of acceptance&commitment therapy for type 2 diabetes
Systematic review and meta-analysis of acceptance&commitment therapy for type 2 diabetes
Japan |
type 2 diabetes
Endocrinology and Metabolism | Psychosomatic Internal Medicine |
Others
NO
Verification of usefulness and safety of ACT for type 2 diabetes
Safety,Efficacy
HbA1c change from baseline within 3 to 6 months and closest value after 3 months
Self-care ability
*Summary of Diabetes Self-Care Activities(SDSCA)
All adverse events
Acceptance ability
*Acceptance and Action Diabetes Question (AADQ)
Others,meta-analysis etc
18 | years-old | <= |
Not applicable |
Male and Female
type 2 diabetes
Patients with high blood sugar that could not be diagnosed by standard diagnostic system
Gestational diabetes
0
1st name | Yoichi |
Middle name | |
Last name | Ohtake |
Itami Seifu Hospital
Internal medecine
664-0011
5-79, Imoji, Itami Shi, Hyogo Ken
072-778-0500
dmactsr@gmail.com
1st name | Yoichi |
Middle name | |
Last name | Ohtake |
Itami Seifu Hospital
Internal medecine
664-0011
5-79, Imoji, Itami Shi, Hyogo Ken
072-778-0500
dmactsr@gmail.com
Itami Seifu Hospital
Japan Society of Psychosomatic Medicine
Other
Itami Seifu Hospital
5-79, Imoji, Itami Shi, Hyogo Ken
072-778-0500
dmactsr@gmail.com
NO
2019 | Year | 07 | Month | 01 | Day |
Unpublished
Preinitiation
2019 | Year | 06 | Month | 30 | Day |
2019 | Year | 07 | Month | 01 | Day |
2019 | Year | 08 | Month | 31 | Day |
<Search method>
Electronic search
1. The Cochrane Central Register of Controlled Trials (CENTRAL);
2. MEDLINE via Ovid;
Other resources
1. The World Health Organization International Clinical Trials Platform Search Portal (ICTRP)
2. Embase
<Meta-analysis>
Implemented using Review Manager software (RevMan 5.3). Use Random-effects model.
<Subgroup analysis>
Perform the following subgroup analysis to assess clinical research participant and intervention heterogeneity.
1. ACT session; less than 12 times, greater than or equal to 12 times
2. BMI; less than 30, greater than or equal to 30
<Sensitivity analysis>
Perform the following sensitivity analysis on primary outcomes.
1. Exclusion of studies using imposed statistics.
2. Missing participants:
Best-best scenario: all missing patients in the two groups remain unchanged
Best-worst scenario: all missing patients in the intervention group remaining unchanged and all missing patients in the control group have outcomes
Worst-best scenario: all missing patients in the intervention group have outcomes and all missing patients in the control group remain unchanged
* primary analysis (worst-worst scenario: all missing patients in the two groups have outcomes)
2019 | Year | 07 | Month | 01 | Day |
2019 | Year | 06 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042173
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |